-
Mashup Score: 10Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology | Research To Practice - 12 day(s) ago
Register for this complimentary event with the “Register Now” button above, which will take you to our Zoom registration page. Join us on Wednesday, May 8 th for this CME/MOC-accredited webinar 5:00 PM – 6:00 PM ET Faculty Justin F Gainor, MD Director, Center for Thoracic Cancers Program Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Boston, Massachusetts Karen Reckamp,
Source: m.researchtopractice.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 11
Location Henry B González Convention Center 900 E Market Street San Antonio, Texas Phone: (210) 207-8500 Program Schedule — Central Time 7:30 AM – 8:00 AM — Registration and Breakfast 8:00 AM – 10:00 AM — Educational Meeting Meeting Room Hemisfair Ballroom — C2 (Ballroom Level) This event will also be webcast live. Please see Registration tab for details. There is no registration fee for this event. For the in-person symposium in San Antonio, preregistration is required as seating is limited. Faculty
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9What I Tell My Patients: Integrating New Research Information into Current Clinical Care | Research To Practice - 2 month(s) ago
This unique NCPD symposium series has been designed to assist oncology nurses as they attempt to optimize patient care and interpret recent clinical and research advances. Moderated by Dr Neil Love, each event will feature a stellar faculty to include 2 or 3 clinical investigators and 2 nurse practitioners. To support the theme of the project, each faculty member will develop several minipresentations designed to elucidate “What I Tell My Patients” about specific management issues or topics. The faculty
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Andrea Cercek, Dr Cathy Eng and Dr John Strickler, moderated by Dr Christopher Lieu. Published February 14, 2024. (Symposium Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers. LEARNING OBJECTIVES Develop an understanding of validated biomarkers of response in patients with metastatic colorectal
Source: m.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0
Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman. Published February 26, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematology-oncology fellows, surgeons and other allied healthcare professionals involved in the treatment of chronic lymphocytic leukemia. LEARNING OBJECTIVES Individualize the selection of systemic therapy for patients with newly diagnosed chronic lymphocytic leukemia (CLL), considering new research findings, clinical
Source: m.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 3
Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel. Published February 23, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical and radiation oncologists, urologists and other healthcare providers involved in the treatment of hepatobiliary cancers. LEARNING OBJECTIVES Interrogate recently presented trial results establishing the benefit of anti-PD-L1 antibody therapy in combination with anti-VEGF therapy as adjuvant treatment for patients with hepatocellul
Source: m.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Dr Neil Love was joined by Dr Ahmed Omar Kaseb and Prof Arndt Vogel to discuss current and emerging therapies for patients with hepatocellular carcinoma and biliary tract cancers. This event is designated for a maximum of 1.75 AMA PRA Category 1 Credits. https://t.co/jrCfJUkcU3 https://t.co/zjVEErsgI6
-
-
Mashup Score: 4
Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer. Published January 31, 2024. (Webinar Video Proceedings) TARGET AUDIENCE This program is intended for medical oncologists, hematologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of breast cancer. LEARNING OBJECTIVES Implement a long-term clinical plan for the management of localized hormone receptor (HR)-positive, HER2-negative breast cancer, accounting for newly presented clinical
Source: m.researchtopractice.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology | Research To Practice - 1 year(s) ago
Join us on Wednesday, April 19th for this CME/MOC-accredited webinar 5:00 PM – 6:00 PM ET Faculty Pashtoon M Kasi, MD, MS Director, Colon Cancer Research Director, Liquid Biopsy Research Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine Englander Institute for Precision Medicine Division of Hematology and Medical Oncology NewYork-Presbyterian…
Source: m.researchtopractice.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting (Video Lecture) | Research To Practice - 2 year(s) ago
ACCREDITATION STATEMENT Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENT Audio Interview: Research To Practice designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent…
Source: m.researchtopractice.comCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 2
ACCREDITATION STATEMENT Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION STATEMENT Audio Program: Research To Practice designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent…
Source: m.researchtopractice.comCategories: Hem/Oncs, Latest HeadlinesTweet
Join us for the Year in Review Live Webinar | Targeted Therapy for Non-Small Cell Lung Cancer Edition on May 8, 4:30-6pm ET. Dr. Justin Gainor and I will discuss the latest updates with Dr. Neil Love to improve patient care and outcomes. #LCSM https://t.co/1FqK4JD3dB